- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Infirmary Cancer Care ( Site 0157) Mobile, Alabama, United States
- Ironwood Cancer & Research Centers ( Site 0204) Chandler, Arizona, United States
- Palo Verde Cancer Specialists ( Site 0105) Glendale, Arizona, United States
- City of Hope - Phoenix ( Site 0202) Goodyear, Arizona, United States
Clinical trial condition
Lymphoma, Large B-Cell, Diffuse
Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.
59 public trials
6 recruiting studies
Lymphoma, Large B-Cell, Diffuse trial results
NCT07519772
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Colorado Blood Cancer Institute ( Site 7000) Denver, Colorado, United States
- SCRI Oncology Partners ( Site 0100) Nashville, Tennessee, United States
- Instituto Alexander Fleming ( Site 1404) Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
- Sanatorio Nuestra Senora del Rosario ( Site 1403) Rosario, Santa Fe Province, Argentina
Recruiting
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
NCT07101328
- Conditions
- B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +23 more
- Locations
-
- City of Hope Duarte, California, United States
- University of Colorado Denver - School of Medicine - Anschutz Medical Campus Aurora, Colorado, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Yale University School of Medicine - Yale Cancer Center New Haven, Connecticut, United States
NCT06852638
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +37 more
- Locations
-
- Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, China
NCT05800366
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- University of Miami Sylvester Cancer Center Miami, Florida, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Recruiting
A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
NCT06045910
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- University Hospital Birmingham NHS Foundation Trust Birmingham, United Kingdom
- Cambridge University Hospitals Cambridge, United Kingdom
- St James's University Hospital Leeds, United Kingdom
- University Hospital London Hospital London, United Kingdom
Not Yet Recruiting
A Phase III Clinical Trial of High-dose Rituximab (500mg/m²) Combined With CHOP Regimen in the Treatment of Male Patient With Newly Diagnosed Advanced DLBCL
NCT06573645
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
Not specified
Not Yet Recruiting
Plasma cfDNA Testing Guiding the Treatment Decisions of DLBCL
NCT06289959
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- The Second Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT04214444
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +14 more
- Locations
-
- GYAN Tours, France
NCT04849416
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
- Locations
-
- Wannan Medical College Yijishan Hospital Wuhu, Anhui, China
- Beijing Cancer hospital Beijing, Beijing Municipality, China
- Southern Medical University Nanfang Hospital Guangzhou, Guangdong, China
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China